These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32926588)

  • 1. A systematic review of guidelines for dual antiplatelet therapy in coronary artery bypass graft.
    Zhang ZZ; Zhang SZ; Zhou HM; Fan YQ; Liu MH; Zhong XB; Yang DY; Guo Y; Zhuang XD; Liao XX
    Eur J Clin Invest; 2021 Jan; 51(1):e13405. PubMed ID: 32926588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical appraisal of guidelines for coronary artery disease on dual antiplatelet therapy: More consensus than controversies.
    Zhang S; Zhou H; Zhuang X; Yang D; Sun X; Zhong X; Lin X; Hu X; Huang Y; Liao X; Du Z
    Clin Cardiol; 2019 Dec; 42(12):1170-1180. PubMed ID: 31609463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Meta-Analysis Comparing Aspirin Alone Versus Dual Antiplatelet Therapy for the Prevention of Venous Graft Failure Following Coronary Artery Bypass Surgery.
    Hesterberg K; Rawal A; Khan S; Rashid A; Jones D; Siddiqui T; Khader TA; Nayyar M; Shah R
    Cardiovasc Revasc Med; 2020 Jun; 21(6):792-796. PubMed ID: 31672535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal antiplatelet strategy following coronary artery bypass grafting: a meta-analysis.
    Agrawal A; Kumar A; Majid M; Badwan O; Arockiam AD; El Dahdah J; Syed AB; Schleicher M; Reed GW; Cremer PC; Griffin BP; Menon V; Wang TKM
    Heart; 2024 Feb; 110(5):323-330. PubMed ID: 37648436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: An updated meta-analysis.
    Cardoso R; Knijnik L; Whelton SP; Rivera M; Gluckman TJ; Metkus TS; Blumenthal RS; McEvoy JW
    Int J Cardiol; 2018 Oct; 269():80-88. PubMed ID: 30072154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital Variability Drives Inconsistency in Antiplatelet Use After Coronary Bypass.
    Beller JP; Chancellor WZ; Mehaffey JH; Hawkins RB; Byler MR; Speir AM; Quader MA; Kiser AC; Yarboro LT; Ailawadi G; Teman NR
    Ann Thorac Surg; 2020 Jul; 110(1):13-19. PubMed ID: 32057813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting.
    Nagashima Z; Tsukahara K; Uchida K; Hibi K; Karube N; Ebina T; Imoto K; Kimura K; Umemura S
    J Cardiol; 2017 Jan; 69(1):156-161. PubMed ID: 26987791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery.
    Qu J; Zhang H; Rao C; Chen S; Zhao Y; Sun H; Song Y; Liu S; Wang L; Feng W; Wang S; Hu S; Zheng Z
    J Am Heart Assoc; 2021 Jun; 10(11):e020413. PubMed ID: 33998246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?
    Mahla E; Prueller F; Farzi S; Pregartner G; Raggam RB; Beran E; Toller W; Berghold A; Tantry US; Gurbel PA
    Ann Thorac Surg; 2016 Dec; 102(6):2010-2017. PubMed ID: 27378554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-Antiplatelet Therapy After Coronary Artery Bypass Grafting: A Survey of UK Cardiac Surgeons.
    Comanici M; Raja SG
    J Cardiothorac Vasc Anesth; 2023 Dec; 37(12):2517-2523. PubMed ID: 37802690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of aspirin and clopidogrel after coronary artery bypass graft surgery.
    de Leon N; Jackevicius CA
    Ann Pharmacother; 2012 May; 46(5):678-87. PubMed ID: 22570427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Aspirin Monotherapy versus Dual Antiplatelet Therapy Following Coronary Artery Bypass Grafting.
    Hess NR; Sultan I; Wang Y; Thoma F; Kilic A
    Am J Cardiol; 2021 Jun; 148():44-52. PubMed ID: 33667447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward Brief Dual Antiplatelet Therapy and P2Y12 Inhibitors for Monotherapy After PCI.
    Ayoub A; Ayinapudi K; Al-Ogaili A; Panhwar MS; Dakkak W; LeJemtel T
    Am J Cardiovasc Drugs; 2021 Mar; 21(2):153-163. PubMed ID: 32780215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early dual antiplatelet therapy versus aspirin monotherapy after coronary artery bypass surgery: survival and safety outcomes.
    Rocha-Gomes JN; Saraiva FA; Cerqueira RJ; Moreira R; Ferreira AF; Barros AS; Amorim MJ; Pinho P; Lourenço AP; Leite-Moreira AF
    J Cardiovasc Surg (Torino); 2020 Oct; 61(5):662-672. PubMed ID: 32431135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial.
    de Waha A; Sandner S; von Scheidt M; Boening A; Koch-Buettner K; Hammel D; Hambrecht R; Danner BC; Schöndube FA; Goerlach G; Fischlein T; Schmoeckel M; Oberhoffer M; Schulz R; Walther T; Ziegelhöffer T; Knosalla C; Schönrath F; Beyersdorf F; Siepe M; Attmann T; Misfeld M; Mohr FW; Sievers HH; Joost A; Putman LM; Laufer G; Hamm C; Zeymer U; Kastrati A; Radke PW; Lange R; Cremer J; Schunkert H
    Am Heart J; 2016 Sep; 179():69-76. PubMed ID: 27595681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual antiplatelet therapy up to the time of non-elective coronary artery bypass grafting with prophylactic platelet transfusion: is it safe?
    Charif F; Hamdan R; Youness G; El Zein A; Issa M; Jassar Y; Younes M; Saab M
    J Cardiothorac Surg; 2019 Nov; 14(1):202. PubMed ID: 31775803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    ; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery.
    Wang A; Wu A; Wojdyla D; Lopes RD; Newby LK; Newman MF; Smith PK; Alexander JH
    Am Heart J; 2018 May; 199():150-155. PubMed ID: 29754654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study.
    Yan H; Tiemuerniyazi X; Song Y; Xu F; Feng W
    J Cardiothorac Surg; 2020 Jun; 15(1):155. PubMed ID: 32600365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet therapy and coronary artery bypass grafting: Protocol for a systematic review and network meta-analysis.
    Gupta S; Belley-Côté EP; Rochwerg B; Bozzo A; Panchal P; Pandey A; Mbuagbaw L; Mehta S; Schwalm JD; Whitlock RP
    Medicine (Baltimore); 2019 Aug; 98(34):e16880. PubMed ID: 31441862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.